Consumption of a suite of ready-to-eat bioactive foods tied to 8.8 percent drop in LDL cholesterol in four weeks<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Jan. 26, 2022 (HealthDay News) — A suite of ready-to-eat bioactive snacks can meaningfully reduce cholesterol in patients unwilling or unable to take statin drugs, according to a study<\/a> published Jan. 26 in the Journal of Nutrition<\/em>.<\/p>\n Stephen L. Kopecky, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues evaluated the effect of snacks containing a compendium of functional bioactives (\u00e2\u0089\u00a55 g fiber, 1,000 mg \u00cf\u0089-3 fatty acids, 1,000 mg phytosterols, and 1,800 \u00ce\u00bcmol antioxidants per serving) on fasting low-density lipoprotein (LDL) cholesterol in statin candidates unwilling to use or intolerant to statin drugs. For four weeks, 18 men and 36 women used these ready-to-eat snacks as a substitute twice daily.<\/p>\n The researchers found that LDL cholesterol was lowered by a mean of 8.80 percent and total cholesterol dropped a mean of 5.08 percent with treatment foods versus control foods. No other analytes changed with the treatment snacks. There were no significant associations between single-nucleotide polymorphisms and outcomes. Compliance with study snacks was 95 percent.<\/p>\n “Consumption of hedonically acceptable snacks containing a compendium of cholesterol-lowering bioactive compounds can rapidly and meaningfully reduce LDL cholesterol in adult patients unable or unwilling to take statin drugs,” the authors write.<\/p>\n Authors report financial ties to the food industry, including Step One Foods, which provided the trial foods.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n